Overview

No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track

Status:
RECRUITING
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the no-reflow in patients with STEMI after intracoronary glycoprotein IIb/IIIa inhibitors after opening of track in thrombus.
Phase:
NA
Details
Lead Sponsor:
Kafrelsheikh University
Treatments:
Sodium Chloride
Tirofiban